Bilasi 20 mg tablet is a medicine made by Team Pharmaceuticals Ltd. Bilasi is used for the symptomatic treatment of allergic rhino-conjunctivitis, which may be seasonal or perennial, and for urticaria.
There are 82 brands of Bilastine listed in Bangladesh. 9 of them have a lower unit price than Bilasi. The lowest listed price is Blastine 20 mg Tablet at ৳ 10 per unit.
What is Bilasi 20 mg Tablet?
Bilasi 20 mg is a tablet product of Team Pharmaceuticals Ltd. that contains Bilastine. It works by blocking histamine in the body, which is one of the substances involved in allergic reactions. It is used for the symptomatic treatment of seasonal and perennial allergic rhino-conjunctivitis and urticaria. The dose and course are decided by the doctor, who considers the child's age and health.
Uses of Bilasi
Bilasi is used for the symptomatic treatment of allergic rhino-conjunctivitis, which may be seasonal or perennial, and for urticaria. Bilastine, the active ingredient, is a non-sedating antihistamine that helps reduce these allergic symptoms. In these allergic conditions, the body reacts to triggers such as pollen or other substances, and an antihistamine helps relieve the resulting symptoms. The doctor will decide if this medicine is suitable for the person's condition and age.
How to use Bilasi
If a dose is missed, ask the doctor or pharmacist what to do rather than doubling the next dose. Bilasi is taken by mouth. Swallow the tablet with water. The doctor decides the dose and how long it should be taken, and that advice should be followed. Do not change the dose on your own.
Side effects of Bilasi
Your doctor or pharmacist can advise on what to do next. In clinical trials, the side effects most often reported with Bilastine were headache, dizziness, somnolence and fatigue. Anyone who notices a side effect or feels unwell while taking Bilasi should tell their doctor or pharmacist, especially if it continues or worries them. Tell your doctor if you notice any of these or any other unusual effect. Do not stop the medicine on your own without consulting them.
Safety and precautions
Always ask the doctor before giving this medicine. For pregnancy, there are no or limited data on the use of Bilastine in pregnant women, and as a precaution it is preferable to avoid it during pregnancy. Data on use in pregnancy are limited, and use during breastfeeding needs a doctor's decision. Ask your doctor first if any of these apply to you.
Frequently asked questions
Why is Bilasi prescribed?
Bilasi is used for the symptomatic treatment of allergic rhino-conjunctivitis, which may be seasonal or perennial, and for urticaria. Bilastine, the active ingredient, is a non-sedating antihistamine that helps reduce these allergic symptoms.
How should I take Bilasi?
If a dose is missed, ask the doctor or pharmacist what to do rather than doubling the next dose. Bilasi is taken by mouth.
What should I watch for while using Bilasi?
Your doctor or pharmacist can advise on what to do next. In clinical trials, the side effects most often reported with Bilastine were headache, dizziness, somnolence and fatigue.
Bilastine is indicated for symptomatic treatment of allergic rhino-conjunctivitis (seasonal and perennial) and urticaria.
Pharmacology
Bilastine is a non-sedating, long-acting histamine antagonist with selective peripheral H 1 receptor antagonist affinity and no affinity for muscarinic receptors. Bilastine inhibits histamine-induced wheal and flare skin reactions for 24 hours following single doses.
Dosage & Administration
Adults & adolescents (12 years of age and over): 20 mg tablet once daily for symptomatic relief of allergic rhinitis, urticaria and allergic rhinoconjunctivitis. The maximum recommended daily dose is 20 mg Bilastine (1 tablet) and should not be exceeded. If a dose is missed, the next scheduled dose should be taken. An extra dose should not be taken. 20 mg Bilastine tablet (1 tablet) once daily should be swallowed with water on an empty stomach to achieve optimal exposure to Bilastine.
Children between 6 to 11 years: 10 mg mouth dissolving tablet for the symptomatic relief of allergic rhinitis, allergic rhinoconjunctivitis and urticaria. The Mouth dissolving tablet is for oral use only. It should be placed in the mouth. It will disperse rapidly in saliva and can be easily swallowed. Alternatively, the mouth dissolving tablet can be dispersed in a tea spoon of water before being swallowed by the children. The maximum recommended daily dose for children in between 6 to 11 years is 10 mg Bilastine mouth dissolving tablet (1 tablet) and should not be exceeded. If a dose is missed, the next scheduled dose should be taken. An extra dose should not be taken.
Children between 2 to 11 years: 4 ml once daily.
Interaction
Concomitant intake of Bilastine and Ketoconazole or Erythromycin or Diltiazem increased C max of Bilastine. The psychomotor performance after concomitant intake of alcohol and Bilastine was similar to that observed after intake of alcohol and placebo. Concomitant intake of Bilastine and Lorazepam 3 mg for 8 days did not potentiate the depressant CNS effects of Lorazepam.
Contraindications
Bilastine is contraindicated in patients with hypersensitivity to the active substance or to any of the excipients of the tablet.
Side Effects
The most commonly reported side effects in clinical trial are headache, dizziness, somnolence and fatigue. These adverse events occurred with a comparable frequency in patients receiving placebo.
Pregnancy & Lactation
There are no or limited amount of data from the use of Bilastine in pregnant women. Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity, parturition or postnatal development. As a precautionary measure, it is preferable to avoid the use of Bilastine during pregnancy. The excretion of Bilastine in milk has not been studied in humans. A decision must be made taking into account the benefit of breast-feeding for the child and the benefit of Bilastine therapy for the mother.
Precautions & Warnings
Co-administration of Bilastine and P-glycoprotein inhibitors (e.g. Ketoconazole, Erythromycin, Cyclosporine, Ritonavir or Diltiazem) should be avoided in patients with moderate or severe renal impairment.
Overdose Effects
In clinical trials, after administration of Bilastine at doses 10 to 11 times the therapeutic dose (220 mg as single dose; or 200 mg/day for 7 days) frequency of treatment-emergent adverse events was two times higher than with placebo. The adverse reactions most frequently reported were dizziness, headache and nausea. No serious adverse events and no significant prolongation in the QTc interval were reported.
Storage Conditions
Keep below 30°C temperature, protected from light and moisture. Keep out of reach of children.
Alternative brands of Bilastine
Other brands with the same generic name, cheapest first.